NASDAQ Companies

Four Core Programs Leverage Unique Attributes in Product Development and Trial Design to Demonstrate the Unmatched Potential of an Allogeneic […]

IRVINE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”) (NASDAQ: KRUS), a […]

DOYLESTOWN, Pa., Jan. 04, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical […]

SÃO PAULO, Brazil, Jan. 04, 2024 (GLOBE NEWSWIRE) — Lavoro (Nasdaq: LVRO), the first U.S.-listed pure-play agricultural inputs distributor in […]

Company anticipates Q4 2023 net FUROSCIX revenue to be approximately $5.9 to $6.1 million; full-year net FUROSCIX revenue of approximately […]

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (“Aeries” or “the Company”) (Nasdaq: AERT), a global professional […]

HOUSTON, Jan. 04, 2024 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (NASDAQ: GLDD), […]

SAN JOSE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA) today announced that Joseph Guiliano was appointed […]

— Company Doses First Participants in Phase 2 Portion of Ongoing VAX-31 Phase 1/2 Study in Adults Following Independent Review of […]

WATERTOWN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to […]